Lv4
780 积分 2025-12-14 加入
IL-33/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation
1小时前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies
1个月前
已完结
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
1个月前
已完结
Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
1个月前
已完结
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
1个月前
已完结
Mosunetuzumab, a CD20xCD3 bispecific T-cell engager, in granulomatosis with polyangiitis
1个月前
已完结
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
1个月前
已完结
Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT‐18 in Chinese Patients With Systemic Lupus Erythematosus
1个月前
已完结
皖公网安备34019202002308
